Effektivnost' primeneniya preparata Lavenum patsientami s perelomami skeleta razlichnykh lokalizatsiy, oslozhnennymi obshirnymi podkozhnymi krovoizliyaniyami


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article presents the substantiation and scheme of application of Lavenum gel in the complex treatment of patients with closed fractures of the limbs of different locations. Clinical, physiological and laboratory results demonstrating the effectiveness of the gel are discussed. Application of Lavenum gel in the treatment of patients with closed fractures of the limbs contributed to optimizing the regenerative processes in the tissues of the damaged segment, leading to shorter fixation at device by an average of 7-10 days compared with patients who were treated without the use of a gel.

Texto integral

Acesso é fechado

Bibliografia

  1. Балуда В.П., Балуда М.В., Деянов И.И., Тлепушков И.К. Физиология системы гемостаза. М., 1955.
  2. Котельников М.В. Тромбоэмболия легочной артерии. Методические рекомендации. М., 2002.
  3. Лечение острого коронарного синдрома без стойких подъемов сегмента ST на ЭКГ. Российские рекомендации // Кардиология. Прил. 2001. № 10.
  4. Шилов А.М., Мельник М.В. Тиклин в профилактике и лечении сердечно-сосудистых заболеваний // Рос. мед. вести 2003. № 4. С. 42.
  5. Шиффман Ф.Д. Патофизиология крови. Пер. с англ. М., 2000. С. 191-82.
  6. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) investigators. Effects of dopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494.
  7. Mehta S, Ysuf S, Peters R, at al. Effects of pretreatment with clopidogrel and aspirin fallowed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527.
  8. The Assessment of the Safety and Efficacy of a New Thrombolytc Regimen. (ASSENT) -3 investigators. Efficacy and safety of tenecteplase in comination with enoxaparine, aboximab or unfractionated heparin: the ASSENT - 3 randomised trial in acute myocardial infarction. Lancet 2001; 358:605.
  9. СавельевВ.С.,ГологорскийВ.А.,КириенкоА.И. и др. Флебология: Руководство для врачей / Под ред. В.С. Савельева. М., 2001. 664 с.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies